Ian W. Flinn, MD, PhD, on Chronic Lymphocytic Leukemia: Early-Phase Research on Immunotherapy

Posted: Monday, August 19, 2019

Ian W. Flinn, MD, PhD, of the Sarah Cannon Research Institute, discusses the ZUMA-8 trial, a phase I/II multicenter study evaluating the safety and efficacy of KTE-X19 in adults with relapsed/refractory chronic lymphocytic leukemia.